79 related articles for article (PubMed ID: 20154487)
21. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.
Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH
Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125
[TBL] [Abstract][Full Text] [Related]
22. [A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].
Hisamatsu K; Iwamori S; Minami K; Tanabe K; Ota K; Akiyama H
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1327-30. PubMed ID: 9279354
[TBL] [Abstract][Full Text] [Related]
23. Fifteen-second skin icing using a frozen gel pack is effective for reducing goserelin injection pain.
Naya Y; Hagiwara N; Takeuchi I; Mori M; Inagaki A; Nakanouchi T; Mikami K
Urol Int; 2014; 93(2):202-6. PubMed ID: 24287721
[TBL] [Abstract][Full Text] [Related]
24. [Drawbacks of ovarian ablation with goserelin in women with breast cancer].
Franco S; Lupa P; Guerra C; Pereira L; Oliveira CF
Acta Med Port; 2005; 18(2):123-7. PubMed ID: 16202345
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Sverrisdottir A; Nystedt M; Johansson H; Fornander T
Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828
[TBL] [Abstract][Full Text] [Related]
26. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
[TBL] [Abstract][Full Text] [Related]
27. Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.
Jiménez-Gordo AM; de las Heras B; Zamora P; Espinosa E; González-Barón M
Gynecol Oncol; 2000 Jan; 76(1):126-7. PubMed ID: 10620455
[TBL] [Abstract][Full Text] [Related]
28. Aromatase inhibitor withdrawal response in metastatic breast cancer.
Cigler T; Goss PE
J Clin Oncol; 2006 Apr; 24(12):1955-6. PubMed ID: 16622274
[No Abstract] [Full Text] [Related]
29. [Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].
Mitsuyama S; Nomura Y; Ohno S; Miyauchi M; Yamamoto N; Kimura T; Saku M; Miura S; Yoshikawa N; Tsujinaka T; Koh J; Ishida T; Abe O; Ohashi Y
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2071-7. PubMed ID: 16352931
[TBL] [Abstract][Full Text] [Related]
30. High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
Pohl G; Rudas M; Dietze O; Lax S; Markis E; Pirker R; Zielinski CC; Hausmaninger H; Kubista E; Samonigg H; Jakesz R; Filipits M
J Clin Oncol; 2003 Oct; 21(19):3594-600. PubMed ID: 14512390
[TBL] [Abstract][Full Text] [Related]
31. Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?
Malayeri R
J Clin Oncol; 2003 Jun; 21(12):2444-5; author reply 2446-7. PubMed ID: 12805348
[No Abstract] [Full Text] [Related]
32. [Study on the administration of goserelin. Methodology and results].
Quesnel M
Soins; 2007 Mar; (713):28-9. PubMed ID: 17419564
[No Abstract] [Full Text] [Related]
33. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia.
Mansel RE; Goyal A; Preece P; Leinster S; Maddox PR; Gateley C; Kubista E; von Fournier D
Am J Obstet Gynecol; 2004 Dec; 191(6):1942-9. PubMed ID: 15592276
[TBL] [Abstract][Full Text] [Related]
34. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
[TBL] [Abstract][Full Text] [Related]
35. [Endocrine therapy for advanced or recurrent breast cancer].
Sonoo H; Kurebayashi J
Gan To Kagaku Ryoho; 2001 Jul; 28(7):909-16. PubMed ID: 11478139
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study.
Baum M; Hackshaw A; Houghton J; Rutqvist ; Fornander T; Nordenskjold B; Nicolucci A; Sainsbury R;
Eur J Cancer; 2006 May; 42(7):895-904. PubMed ID: 16545560
[TBL] [Abstract][Full Text] [Related]
37. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
Pollack A; Horwitz EM
Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
[No Abstract] [Full Text] [Related]
38. [Endocrine therapy for prostate cancer in the future].
Usami M
Gan To Kagaku Ryoho; 1998 May; 25(6):817-22. PubMed ID: 9617319
[TBL] [Abstract][Full Text] [Related]
39. The biology of steroid hormones and endocrine treatment of breast cancer.
Dowsett M; Folkerd E; Doody D; Haynes B
Breast; 2005 Dec; 14(6):452-7. PubMed ID: 16198110
[TBL] [Abstract][Full Text] [Related]
40. Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!
Samur M; Bozcuk HS
J Clin Oncol; 2003 Jun; 21(12):2444; author reply 2445-7. PubMed ID: 12805349
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
